This is often the first question patients ask their doctor, and it's an important one. The honest answer is: it depends on the stage, type and individual characteristics of the cancer, but there is real hope.
Early-stage lung cancer (stages 1 and 2) is highly treatable. Surgery, SABR or combination approaches with perioperative chemotherapy and immunotherapy offer excellent chances of long-term control and in many cases, cure. Many patients go on to live full, active lives after treatment. With modern medicines and techniques, outcomes for early stage cancer continue to improve.
Locally advanced lung cancer (stage 3) can be treated with curative intent. Advances in chemoradiotherapy, immunotherapy and precision radiation therapy like proton beam therapy and SABR mean that more people are achieving excellent long-term outcomes. I'm now able to offer treatment aimed at long-term control to patients who might have been told their cancer was too advanced just a few years ago. Cure is possible for some people with rapid access to the right treatment.
Advanced lung cancer (stage 4) is more challenging. Modern systemic therapy, including immunotherapy and targeted therapy drugs, can control the disease for extended periods, maintaining quality of life and allowing precious time with loved ones. For carefully selected patients with oligometastatic disease (cancer spread to only a few sites), combination treatment with systemic therapy and SABR can be aimed at long-term disease control.
The key is not to assume what's possible based on outdated information. If your doctor hasn't discussed proton beam therapy, MR-linac treatment, clinical trials, SABR or combination approaches with you, we should talk.